biomodal has just announced it has filed a lawsuit against New England Biolabs in the United States District Court for the District of Massachusetts.
An Epigenome Wide Association Study (EWAS) investigates the relationship between epigenetic modifications and traits/diseases. Learn why they are important.
Formalin-Fixed Paraffin-Embedded (FFPE) tissue plays a critical role in histopathological diagnosis, and it is particularly valuable in the diagnosis of diseases like cancer.
We are delighted to present BaseSpace Sequence Hub data for duet multiomics solution +modC.
RNA sequencing (RNA-seq) has become immensely popular and indispensable in modern biological research. We look at the considerations and challenges of this technology.
Novel solution – duet evoC – distinguishes 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) revealing unprecedented insights into current and future states of disease using one 5ng DNA sample
A Q&A with Peter Fromen, CEO of biomodal, emphasising the potential applications of their technology, particularly in oncology, liquid biopsy, aging, and neurodegenerative disorders.
Discover how new technology in next generation sequencing can capture the standard A, C, G, T bases plus epigenetic information in a single workflow.
Uncover the role of DNA methylation in Alzheimer’s disease research, from biomarker discovery to therapeutic potential.
John McShane recently joined biomodal as our Director of Business Development for Eastern North America and Canada.